Skip to main content
. 2021 Apr 21;11:618767. doi: 10.3389/fonc.2021.618767

Figure 1.

Figure 1

A summary of the genomic characteristics of 589 Chinese breast cancer patients. Oncoprint showed genetic changes with an incidence of more than 2%. According to the HR and HER2 status, the tumor samples were stratified into: HR+/HER2 (n = 321), HR+/HER2+ (n = 111), HR−/HER2+ (n = 64), triple-negative (n = 68), and unknown (n = 25). The sidebar summarizes the percentage of tumors with mutations in each gene. Different colors indicate different types of mutations. Clinicopathological features were annotated at the bottom. Indel, insertion or deletion variations; CN_amp, copy number amplification; CN_del, copy number deletion.